Alberto Carlos Reino: Diabetes and the Hidden Cardiovascular–Renal Reality
Alberto Carlos Reino, Nephrologist at Nefron SAS, Co-Founder and CMO, Functional Nephrologist at Nephrohealth KA, shared a post on LinkedIn about a recent article by José Luis Górriz and Juan F. Navarro-González published in NephSAP:
“Diabetes and the Hidden Cardiovascular–Renal Reality
In 2021, an estimated 537 million people worldwide were living with diabetes.
- 95% have Type 2 diabetes
- 5% have Type 1 diabetes
But the real concern lies beyond glucose levels.
Diabetic Kidney Disease (DKD) develops in:
- Approximately 40% of people with Type 2 diabetes
- Approximately 30% of people with Type 1 diabetes
Diabetes now accounts for half of all chronic kidney disease (CKD) cases globally.
Yet the most striking fact is this:
90% of patients with DKD do not reach kidney failure.
They die earlier — primarily from:
- Heart failure
- Atherosclerotic cardiovascular disease
Only 10% survive long enough to require dialysis or transplantation.
Clinical implication
DKD is not just a renal disease.
It is a cardio-renal syndrome with high mortality.
Managing diabetic kidney disease means:
- Early screening (albuminuria and eGFR)
- Aggressive cardiovascular risk reduction
- RAAS blockade, SGLT2 inhibitors, GLP-1 receptor agonists when indicated
- Multidisciplinary care
The real endpoint is not dialysis.
It is cardiovascular survival.”
Title: Diabetic Kidney Disease
Authors: José Luis Górriz, Juan F. Navarro-González
Read the Full Article on NephSAP.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 1, 2026, 11:07Yashaswi Dhiman: Advancing Hemovigilance Through Award-Winning Science
-
Aug 1, 2026, 08:24Kayla Garrett: Transforming Expectations in Haemophilia A Care
-
Aug 1, 2026, 07:51Toyosi Onwuemene: Are We Measuring the Outcomes That Matter Most to Patients With TTP?
-
Aug 1, 2026, 07:51Christopher Kirkham: Could Platelet Activation Become a Liability for Your Antibody Programme?
-
Aug 1, 2026, 07:38Danny Hsu: Recognizing Excellence in Scientific Leadership at ISTH 2026
-
Aug 1, 2026, 07:24Ulrich Sachs: A New Strategy to Prevent Platelet Transfusion Refractoriness
-
Aug 1, 2026, 07:12Gijs Aertssen: New Evidence on Joint Prosthesis Survival in Inherited Bleeding Disorders
-
Aug 1, 2026, 06:58Nora Abazi Emini: New Insights into Factor XIII in Atypical Haemolytic Uraemic Syndrome
-
Aug 1, 2026, 06:30Understanding Natural Anticoagulant Deficiencies – JTH